Join us for this year's prestigious President’s Lecture, a highlight of the BPS calendar! This year, our President, Professor Sir Mark Caulfield, invites Dr Peter Cox as guest speaker.
 
Dr Cox is a biologist with over 25 years experience working in the pharmaceutical and biotech industries. He has worked at Pfizer and BenevolentAI (BAI) - a pioneering AI-led drug discovery company. Peter is currently Head of the Translational Science team at Isomorphic Labs, which is developing and applying frontier AI to reimagine and advance the drug design process to unlock deeper scientific insights and faster breakthroughs. Peter’s team of in vitro pharmacologists / translational biologists are responsible for the biology strategy of Isomorphic Labs’ AI-led drug design projects and provides critical validation for their innovative in-silico predictions through the generation of experimental biological data, directly advancing the evolution of some of the most sophisticated and powerful AI drug design platforms.
 
Join Peter for his talk, "A Pharmacology Perspective of AI in Drug Discovery". You'll learn about the transformative role of artificial intelligence in pharmacological and drug discovery, and what the future holds.
 
Don't miss this unique opportunity to hear from one of the leaders at the intersection of AI and pharmacology, network with peers, and take part in critical discussions.